Digital Pathology News
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business. The image analysis algorithms will be deployed on Roche's...
Proscia: Key regulatory milestone advances company’s mission to perfect cancer diagnosis. PHILADELPHIA – February 12, 2024 – Proscia®, a leading provider of digital and computational pathology solutions, has received 510(k) clearance...
Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea, a trailblazing digital...
Nijmegen, the Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a distribution collaboration with Paige, a global leader in AI-based...
Corista: DP3’s momentum as a world-class integrated pathology solution grows Concord, MA (Feb. 7, 2024) – Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License...
From Aiosyn blog: Diana Rosentul, a Regulatory Affairs Specialist at Aiosyn, intricately manages the regulatory landscape associated with the integration of AI-based solutions within clinical and research institutions. Drawing upon her...
